C07C 405/0033
Containing sulfur
Official title: {containing sulfur}
C07C405/0033 (Containing sulfur) appears on 136 US grants and 10 published applications in this corpus.
Search patents in C07C- Granted patents
- 136
- Published applications
- 10
- Assignees
- 36
- Inventors
- 192
- Latest grant
- 26 Jun 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 17 | 0 |
| 1978 | 14 | 0 |
| 1979 | 14 | 0 |
| 1980 | 20 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 1 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient26 Jun 2012US 8,207,223 B2Ono Pharmaceutical Co., Ltd.
- Process for preparation of 13,14-dihydro-PGF2 alpha derivatives1 Mar 2011US 7,897,793 B2Instytut Farmaceutyczny
- Prostaglandin derivatives27 Jul 2010US 7,763,652 B2Taisho Pharmaceutical Co., Ltd.
- Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient27 Oct 2009US 7,608,637 B2Ono Pharmaceutical Co., Ltd.
- 2,3,4-substituted cyclopentanones as therapeutic agents27 Feb 2007US 7,183,324 B2Allergan, Inc.
- Prostaglandin analogs and uses thereof13 May 2021US 2021/0139435 A1Lifex Biolabs, Inc.
- Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient9 Aug 2012US 2012/0202773 A1Ono Pharmaceutical Co., Ltd.
- Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient14 Jan 2010US 2010/0010222 A1Ono Pharmaceutical Co., Ltd.
- Process for preparation of 13,14-dihydro-pgf2 alpha derivatives9 Apr 2009US 2009/0093651 A1Instytut Farmaceutyczny
- Process for preparation of 13,14-dihydro-pgf2 alpha derivatives28 Aug 2008US 2008/0207926 A1Instytut Farmaceutyczny
Most cited
By later US patents
- 3-Hydroxybutyric acid polymers114US 4,427,614 AImperial Chemical Industries PLC · 1984
- Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions75US 4,311,707 AAmerican Cyanamid Company · 1982
- 1 And 2-substituted analogues of certain prostaglandins41US 4,171,331 AMiles Laboratories, Inc. · 1979
- Difluoroprostaglandin derivatives and their use29US 5,886,035 AAsahi Glass Company, Limited · 1999
- 3,7-dithiaprostanoic acid derivative29US 5,892,099 AOno Pharmaceutical Co., Ltd. · 1999